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ABSTRACT
Objectives To investigate the relation between volume
and mortality after adjustment for case mix for radical
cystectomy in the English healthcare setting using
improved statisticalmethodology, taking into account the
institutional and surgeon volume effects and institutional
structural and process of care factors.
Design Retrospective analysis of hospital episode
statistics using multilevel modelling.
Setting English hospitals carrying out radical cystectomy
in the seven financial years 2000/1 to 2006/7.
Participants Patients with a primary diagnosis of cancer
undergoing an inpatient elective cystectomy.
Main outcome measureMortality within 30 days of
cystectomy.
Results Compared with low volume institutions, medium
volume ones had a significantly higher odds of in-hospital
and total mortality: odds ratio 1.72 (95% confidence
interval 1.00 to 2.98, P=0.05) and 1.82 (1.08 to 3.06,
P=0.02). This was only seen in the final model, which
included adjustment for structural and processes of care
factors. The surgeon volume-mortality relation showed
weak evidence of reduced odds of in-hospital mortality
(by 35%) for the high volume surgeons, although this did
not reach statistical significance at the 5% level.
Conclusions The relation between case volume and
mortality after radical cystectomy for bladder cancer
became evident only after adjustment for structural and
process of care factors, including staffing levels of
nurses and junior doctors, in addition to case mix. At
least for this relatively uncommon procedure, adjusting
for these confounders when examining the volume-
outcome relation is critical before considering
centralisation of care to a few specialist institutions.
Outcomes other than mortality, such as functional
morbidity and disease recurrence may ultimately
influence towards centralising care.
INTRODUCTION
The relation between volume and outcome in health
care, based on Donabedian’s structure-process-out-
come paradigm,1 has influenced English health policy,
with centralisation of oncology services across several
specialties.2 Despite large amounts of evidence sup-
porting higher volume-better outcomes,3 several stu-
dies have shown that surgeons or institutions with
low volume caseloads can have excellent outcomes
and some high volume surgeons or institutions can
have poor outcomes.4 This, along with variability
between studies in the magnitude of the volume-out-
come relation reported, has led authors to question the
methodological quality of existing studies and also
show that improved methodology can attenuate pre-
viously reported results.5 The most consistent
volume-outcome relations have been for procedures
such as pancreatectomy and oesophagectomy, prob-
ably because they have sufficient case denominators
and frequency of measurable adverse events to show
differences between providers.6 Within urology, radi-
cal cystectomy has been commonly used for volume-
outcome research and it has been included in reforms
striving to improve outcomes for cancer treatments.2
The US Institute of Medicine critically appraised the
volume-outcome relation in the context of healthcare
quality and produced a methodological scoring system
that determines a study’s ability to discern a true volume-
outcome relation. For oncology studies published
between 1984 and2004 these scoreswere onlymodest at
best6 and had not improved significantly from those in a
previous systematic review.7 Similar findings have been
reported for studies specific to uro-oncology,8 and over
90% of these studies originated outside of theUKhealth-
care system, with over 80% from theUnited States.8 Dif-
ferences in the healthcare system limit the transferability
of this information to the UK setting, particularly when
severalUSdatasets do not reflect the entire treated popu-
lation. Assessing the existing literature using this metho-
dological scoring system7 highlighted several important
methodological considerations for volume-outcome
research: the impact of the hierarchical structure of the
institution and surgeon (multilevel modelling), appropri-
ate handling of the provider volume variable, and the
need for adjustment of structural or process of care mea-
sures. We took these considerations into account while
investigating the volume-mortality relation for radical
cystectomy in England.
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METHODS
We took data for inpatient elective cystectomies (code
M34 from the Office of Population Censuses and Sur-
veys Classification of Surgical Operations and Procedures,
fourth revision, occurring in any procedure field in any
episode) from hospital episode statistics for the six
financial years from 2000/1 to 2005/6 and from the
secondary users service for 2006/7. Hospital episode
statistics is the national statistical administrative data-
base for England of the care provided by National
Health Service hospitals. Each record in the database
constitutes a finished consultant episode, which covers
the continuous periodduringwhich a patient, admitted
to a hospital, is under the care of the same consultant,
whose unique identification code (used by the doctor’s
regulatorybody, theGMC) is recorded.We linked epi-
sodes with admissions using the patient’s date of birth,
sex, and postcode; the hospital; and date of admission,
and we linked admissions together if the patient was
transferred to another trust. A hospital trust provides
secondary healthcare services within the NHS, which
can either be planned specialist medical care, surgery,
or emergency care. A trust may comprise several hos-
pital sites.
We excluded people if they were admitted as an
emergency, had an invalid age, sex, or length of stay,
were day cases, or did not have a primary diagnosis of
cancer (codes C66-68 and D090, international classifi-
cation of diseases, 10th revision). For each year we
noted the proportion of patients undergoing cystect-
omy for bladder cancer.
Assignment of institutional and surgeon volume bands
We counted the number of cystectomies by year and
each of consultant code and trust. To account for trust
mergers, we unified trust codes to reflect their status as
of April 2007. Very low volume trusts (institutions)
were excluded if they either had fewer than three
years of data or recorded fewer than two cystectomies
annually. This was to try to capture institutions with
genuine activity—that is, no coding errors. If a provi-
der had less than three years of data, we considered it
unlikely that they were carrying out cystectomy
regularly during the period analysed. This had to be
balanced against not excluding providers (at the sur-
geon level) that either retired or were newly appointed
during the analysed period and may therefore only
appear for three or less years. We thought that this
three year cut-off point, in combination with an annual
cystectomy rate of two, would identify cases more
likely appearing as a result of coding error, while not
inappropriately removing large numbers of low
volume providers—that is, those regularly carrying
out between two and 10 operations per year at the insti-
tution level, or between one and five operations per
year at the surgeon level. On this basis we excluded
13 institutions providing 41 cases (0.5% of total
cases). We put the remainder into three volume
bands of roughly equal total numbers of operations
(table 1).
We allocated consultants to volume bands in a simi-
lar fashion, but because surgeons could operate at
more than one institution, and hence be included in
more than one institutional volume band, allocation
was done in two stages. After we excluded a record
with a missing consultant code, we calculated the sur-
geon’s average annual cystectomy rate. We excluded
consultants if their average cystectomy rate was two or
less cases per year and they had fewer than three years
of data. Because coding errors occur at the level of the
institution, exclusion was done without summating
caseload of consultants operating at multiple institu-
tions. Overall, we excluded 189 consultants providing
313 operations (3.6% of total cases). We then recalcu-
lated the annual cystectomy rate for those surgeons
operating at more than one institution, using the max-
imum number of years practised from whichever pro-
vider and total summation of operations. Consultants
were then divided into three volume bands of roughly
equal operation numbers (table 1).
Outcome measures
We assessed all cause mortality within 30 days of
cystectomy (or admission if the date of procedure was
missing) in two ways: in-hospital mortality andmortal-
ity either in or out of hospital (total mortality). We
Table 1 | Number of operations by institutional and surgeon volume bands, generated before regression modelling
Variables
Institutional volume* Surgeon volume*
Low
(>2 and <10)
Medium
(≥10 and <16)
High
(≥16)
Low
(≥1 and <5)
Medium
(≥5 and ≤8)
High
(>8)
Financial year:
2000/1 453 331 346 485 315 264
2001/2 437 383 359 511 306 303
2002/3 495 370 378 506 357 356
2003/4 461 392 398 480 388 359
2004/5 431 387 416 419 366 413
2005/6 375 425 463 334 405 490
2006/7 384 488 424 314 423 529
No of operations 3036 2776 2784 3049 2560 2714
No of institutions or surgeons 84 31 19 228 78 40
*Annual cystectomy rate.
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calculated total mortality by using a date of death
linked to hospital episode statistics by the Office for
National Statistics. This was unavailable for 2006/7,
but to avoid losing a year’s records and to maintain
statistical power, we assumed that no deaths occurred
out of hospital in 2006/7; we undertook a sensitivity
analysis on the small shortfall (see appendix 1 on
bmj.com).
Volume-mortality analysis
We used four different models of increasing complex-
ity to assess the volume-mortality relation (see appen-
dix 1 for details). In summary, eachmodel assessed the
relation between each volume variable (surgeon and
institution) and mortality. Model 1 did not adjust for
any other variables. Model 2 adjusted for patient case
mix. Model 3 also took account of the “clustering” of
patientswithin surgeons and surgeonswithin hospitals.
Finally,model 4 included adjustment for structural and
process of care variables.
We present volume-mortality relations as odds
ratios, with the low volume band as the reference
group. The interaction effects between institution and
surgeon volumes were assessed.
Statistical analysis
Using χ2 tests we assessed variations in case mix vari-
ables within volume groups and between volume
groups. All logistic regression and other statistical ana-
lysis except for multilevel modelling (done using
PROC GLIMMIX in SAS version 9.2) were done
using the SPSS package version 14 for Windows.
RESULTS
The number of radical cystectomies carried out each
year increased steadily from 1130 in 2000/1 to 1296 in
2006/7 (P=0.005 for linear trend). Table 1 shows the
distribution by institution and surgeon volume. A sig-
nificant downward trend occurred in total mortality,
from 3.5% in 2000/1 to 2.1% in 2005/6 (deaths out of
hospital were not available for 2006/7). Table 2 shows
observedmortality by institution and surgeon volume.
Characteristics of patients and institutions
The proportion of treated patients aged 75 years or
more increased from 19.8% in 2000/1 to 22.7% in
2006/7 (P=0.03). The proportion of men was signifi-
cantly greater in 2000/1 and 2003/4 than in the other
years (P=0.03). The proportion of patients in the high-
estCharlson category (6+)9 varied significantly year on
year, but with no linear trend across the years. For
every year the median Charlson score9 and Carstairs
fifths10 were 2 and 3, respectively.
Medium volume institutions treated proportionally
fewer patients in the most deprived Carstairs fifth
(highest fifth) and a greater proportion of patients
older than 75 (P<0.01, table 3). The number of institu-
tions with teaching status increased significantly from
the low volume group to the high volume group
(P<0.01). Medium and high volume surgeons treated
a greater proportion of men and fewer patients in the
most deprived Carstairs fifth (P<0.01). Medium and
high volume surgeons more often worked in
Table 2 | Observed rates for in-hospital and total mortality
within 30 days of cystectomy, stratified by institutional and
surgeon volume bands. Values are numbers (percentages) of
patients
Volume bands In-hospital mortality Total mortality
Institutional volume:
Low 85 (2.8) 90 (3.0)
Medium 82 (3.0) 90 (3.2)
High 56 (2.0) 66 (2.4)
Surgeon volume:
Low 86 (2.8) 92 (3.0)
Medium 74 (2.9) 81 (3.2)
High 52 (1.9) 62 (2.3)
Table 3 | Differences in characteristics of patients and institutions by provider volume group
Provider % of men
Charlson score
(% in category 6+)* Age (% >75 years)
Carstairs score
(% in category 5)†
Teaching status
(% within volume group)
Institution
Volume band:
Low 75.3 1.6 17.8 15.2 9.7
Medium 76.3 1.9 23.0 12.4 19.1
High 76.5 2.1 20.9 15.5 41.2
P value‡ 0.47 0.45 <0.01 <0.01 <0.01
Surgeon
Volume band:
Low 74.2 1.6 19.4 16.0 19.4
Medium 76.3 2.0 21.2 13.9 25.4
High 78.2 2.3 21.0 12.6 24.2
P value‡ <0.01 0.12 0.19 <0.01 <0.01
*Category 6+ represents patients with worse comorbidity scores.9
†Carstairs deprivation scores for every output area (about 500 residents on average) in England were converted into fifths with equal populations in
each and assigned to every record through postcode using a look-up file from ONS Gridlink.10 Category 5 represents patients with worse deprivation
score.
‡χ2 test.
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institutions with teaching status than low volume sur-
geons. Differences in the structural and process of care
variables were significant across the bands for institu-
tional volume (table 4).
Volume-mortality relation
Formediumvolume institutions inmodel 3 the odds of
in-hospital mortality was 1.16, but increased to 1.72
(95% confidence interval 1.00 to 2.98, P=0.05) in
model 4 (including adjustment for the structural and
process of care variables). Adjusting for the ratio of
the number of nurses to occupied beds increased the
odds to 1.31; this became 1.52 after adjusting for the
ratio of urology registrars to total urology episodes,
and 1.62 after including waiting time for operations.
Adding the remaining structural and process of care
variables tomodel 4 gave an odds ratio of 1.72. A simi-
lar pattern was seen for total mortality (model 4, 1.82,
1.08 to 3.06, P=0.02). Differences were not significant
when using models 1-3. The only significant result for
high volume institutions was a lower odds of in-hospi-
tal mortality in model 2 (0.67, 0.47 to 0.97, P=0.03;
fig 1).
High volume surgeons had a significantly lower
odds of in-hospital mortality for model 1 (0.67, 0.48
to 0.95, P=0.03) and model 2 (0.64, 0.44 to 0.91,
P=0.01), but this became non-significant at the 5%
level in models 3 and 4. Total mortality did not differ
significantly (fig 2).
Figure 3 summarises the adjusted probabilities for
in-hospital and total mortality across both institutional
and surgeon volume bands. Adjusted probabilities
were calculated using model 4.
Interaction effect
We tested for an interaction between the two volume
variables. This resulted in a significant interaction term
(P=0.035) but non-significantmain effects (P>0.1), sug-
gesting no evidence for a convincing interaction effect.
DISCUSSION
Patients undergoing radical cystectomy for bladder
cancer in medium volume (≥10 and <16 procedures
per year) institutions had 72% and 82% greater odds of
30 day in-hospital and total mortality than patients
undergoing the same procedure in low volume (>2
and <10 procedures per year) institutions. This
increased risk in mortality was seen only after adjust-
ment for institutional structural and process variables.
Staffing levels for nursing and urology registrars
Table 4 | Variation in structural and process of care measures between institutional volume bands. Minimum and maximum values are in brackets
Measures
Institutional volume band
Overall mean
One way
ANOVALow Medium High
Ratio of No of nurses to occupied bed count 1.59 (1.12 to 2.60) 1.73 (1.31 to 2.76) 1.75 (1.36 to 2.14) 1.69 <0.01
Ratio of urology registrars to total urology
episodes (×10 000)
4.1 (0.34 to 21) 4.3 (0.2 to 12) 6.3 (0.9 to 15) 4.9 <0.01
Operation waiting time 31.7 (1 to 394) 32.6 (1 to 339) 30.3 (1 to 251) 31.5 <0.01
Ratio of No of critical care beds to total beds 0.021 (0.01 to 0.062) 0.024 (0.009 to 0.055) 0.026 (0.013 to 0.048) 0.023 <0.01
Ratio of registrars (all specialties) to No of
occupied beds
0.09 (0.02 to 0.35) 0.13 (0.06 to 0.47) 0.15 (0.04 to 0.28) 0.12 <0.01
Trust teaching status (% within volume group) 9.7 19.1 41.2 22.9 (overall %) <0.01*
Average occupied acute bed rate 0.85 (0.73 to 0.94) 0.84 (0.76 to 0.92) 0.85 (0.79 to 0.94) 0.85 <0.01
Readmission rate after cancelled operation 0.11 (0.00 to 0.42) 0.10 (0.00 to 0.35) 0.13 (0.01 to 0.33) 0.11 <0.01
Total beds available, all sectors 5372 (2143 to 10 441) 7356 (1686 to 16 745) 9783 (1651 to 18 044) 7441 <0.01
Total acute beds available 4056 (1723 to 8730) 5822 (1686 to 14 285) 7942 (1651 to 13 506) 5884 <0.01
Total urology episodes 25 978 (8688 to 63 818) 39 640 (5132 to 83 112) 49 855 (3402 to 89 385) 38 123 <0.01
ANOVA=analysis of variance.
*χ2 test.
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Fig 1 | Odds ratios and confidence intervals for institutional
volume-mortality relations across four models
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seemed to have the greatest influence, in keeping with
previous studies.11 12
Although not significant at the 5% level, weak evi-
dencewas found for a reduced odds of in-hospitalmor-
tality (by 35%) associated with the high volume (>8
procedures per year) surgeons. Surgeon volume also
seemed to have some protective effect on in-hospital
mortality at the institutional level. After adjustment
for patient case mix alone, high volume institutions
displayed statistically significantly lower odds of in-
hospital mortality. This effect disappeared after adjust-
ing for surgeon volume.
There was relatively little difference in the crude
odds ratio and casemix adjustedodds ratio ofmortality
at both institutional and surgeon level. This is inter-
esting in itself, as surgeons often use variation in case
mix to explain differences in performance. It may be
that adjustment for case mix, using variables as incor-
porated in this study, is not always necessary for analy-
sis of effects at a highly aggregated level, as opposed to
risk prediction at an individual patient level. One
study13 also reported a minimal difference in the unad-
justed and adjusted (for patient characteristics) odds
ratios ofmortality for cystectomy between low volume
and high volume institutions.
Strengths and weaknesses of the study
The median Institute of Medicine quality score7 for
previous studies appraising the volume-outcome rela-
tion for cystectomy was modest, at 8.5 (range 8-11).8
Using the same scoring criteria, the current study
would achieve a higher score of 13 out of a possible
18. One mark was lost because, for practical purposes,
we chose to report on only the volume-mortality rela-
tion and removed all other outcome measures. We
acknowledge, however, that outcomes other thanmor-
tality are important when considering the reconfigura-
tion of health care. Four marks were not achievable
because we used an administrative database and there-
fore couldnot determine the appropriateness of patient
selection for cystectomy or use clinical data for risk
adjustment. Methods to circumvent this limitation
could include linkage of administrative datasets with
local or specialty society datasets and simultaneously
serving to confirm the accuracy of coding. The need to
centrally support such initiatives across the multiple
available datasets has been acknowledged.14 Although
we were unable to adjust data for cancer stage and
grade, when this has been possible it seemed to have
little effect on the reported findings.13 15
It was not possible to carry out a subanalysis of mor-
tality risk for patients who had an ileal conduit diver-
sion or a continent diversion because of
underreporting of continent diversions. Similar diffi-
culties have also been experienced with US adminis-
trative databases.11 Clinicians have for some time
questioned the reliability of coding within hospital epi-
sode statistics. In England, training of coding staff, reg-
ular monitoring of data quality, and a commissioning
system that financially reimburses healthcare provi-
ders according to case mix adjusted activity will have
improved the quality of data completeness and accu-
racy since the early years of hospital episode statistics.
If institutional resources for coding are proportional to
the overall workload of that institution, it is possible
that miscoding rates are not systematically different
by volume of hospital. This will have biased the esti-
mated odds ratios towards 1 and therefore underesti-
mated any volume-mortality relation.
Our definitions for mortality outcome used a 30 day
follow-up only, as is usual.15 Overall, 90 day mortality
is known to be higher than 30 day mortality after
cystectomy,16 but whether this differs across providers
is unclear; work on this and longer term cancer specific
survival should consider postoperative structural and
process of care factors such as ancillary services for
oncology.12 The only previous study that used hospital
episode statistics to assess mortality after cystectomy
included in-hospital mortality only.17 We assumed
that no deaths occurred out of hospital in 2006/7,
rather than the four on average for the other years.
Although this assumption is not expected to have
been true in reality, the sensitivity analysis showed
this was unlikely to have biased the results for this out-
come.
The finding that medium volume institutions have
higher odds of mortality is surprising. Without further
evaluation of potential causative factors, this is difficult
to fully explain. We did not assess the relative contri-
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Fig 2 | Odds ratios and confidence intervals for surgeon
volume-mortality relations across four models
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bution of the institution and surgeon to the volume-
mortality relation. We also did not attempt to define
causal pathways of influence of the structural and pro-
cess of care variables onmortality. Previous studies, for
instance, have shown that for colorectal resections
medium volume surgeons can achieve results for inpa-
tient mortality similar to those of high volume sur-
geons when operating in medium volume or high
volume hospitals but not low volume hospitals.18 Simi-
larly, the contribution of individual institutional struc-
tural variables can be important. When low volume
institutions have asmany residents or interns and regis-
tered nurses per 100 beds as high volume institutions,
overall mortality for paediatric heart surgery and heart
transplants appeared equivalent.19
From the summary of adjusted probabilities (fig 3),
medium volume institutions do seem to have worse in-
hospital and total mortality than high volume institu-
tions, which is consistentwith previous studies.What is
not clear is why low volume institutions seem to have
comparable outcomes to high volume institutions.
Although it would be impossible to refute this finding,
it may be artefactual. The division of volumes into
thirds does not assume a linear relation between
volume andmortality but rather allows for a non-linear
one such as the middle volume having lower or higher
mortality than the lower and higher volumes. It is pos-
sible that our cut-offsmaynot be optimal and thatmore
complex functional forms (for example, quadratics,
splines) may perform better. The plotting of mortality
at unit level against unit volume for our dataset did not
reveal any obvious relations, and we chose thirds
because of statistical power and because such an
approach is commonly used. We did not exclude
large numbers of very low volume providers, which
may have contaminated the low volume third if it con-
tained patient level records present only through cod-
ing errors.
Some of the structural and process of care factors
used in themodel may themselves be acting as proxies
for volume. Several of the variables, such as staffing
levels, critical care facilities, and hospital capacity do
increase across the institutional volumebands (table 4).
In extreme cases this can lead to “colinearity,” with
multiple variables trying to describe the same quantity,
but no convincing evidence of this was shown by
inspection of the standard errors. However, the notice-
able increase in the width of the confidence interval for
the institutional volume group with the addition of the
structural and process variables suggests that we were
at the limit of acceptability for the number of variables
included.
The use of an incremental modelling approach for
volume-outcome research is in itself important for
helping to decide whether volume should be defined
at the institutional or surgeon level, or both. Using the
institution allows for the importance of overall team-
work on outcomes by factoring in institutional factors
that cannot always be measured. It has been acknowl-
edged that existing studies have rarely considered the
relative effects of the unit of analysis and their possible
interactions.20
Comparisons with other studies
A previous study17 used only two volume categories in
its hospital episode statistics based analysis anddefined
an “optimum” annual institutional caseload of 11 cases
per year. Shifting the case volume threshold to 16 cases
per year included more centres with optimummortal-
ity outcomes in the group below the threshold
(<16 cases/year) and therefore found no significant dif-
ference in mortality between the groups.
A systematic review, using a randomeffects analysis,
found an 88% higher odds of mortality for cystectomy
in lowvolume institutions than inhigher volumeones.8
Only five studies could be included, and their metho-
dological quality was assessed as only modest at best.
That the difference was greater than ours can be partly
explained by the limitation of meta-analysis when stu-
dies use different volume cut-off categories and adjust-
ment methods and amalgamate studies from different
healthcare settings.8 US studies using the healthcare
utilisation project found 3.2 times and 1.96 times the
case mix adjusted risk of dying postoperatively in low
volume institutions compared with high volume insti-
tutions (cystectomy rate 1-5/year v ≥20/year12 and
<1.5/year v ≥2.75/year,21 respectively). The direction
of effect is consistent with the results of our study,
although their magnitude of effect was greater.
It could be suggested that the differences in the
annual caseloads between surgeon volume categories
defined in this study are only marginal. Compared
with other studies, however, the cut-offs are relatively
far apart. One study22 showed an adjusted odds ratio
for death postoperatively for patients with a low
volume surgeon (<2 cases/year) compared with those
with a high volume surgeon (>3.5 cases/year) of 1.83
(95% confidence interval 1.37 to 2.45). Conversely,
another study21 found no overall differences in in-
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Fig 3 | Adjusted probabilities (derived from model 4) for in-
hospital and total mortality across institutional and surgeon
volume bands
RESEARCH
page 6 of 8 BMJ | ONLINE FIRST | bmj.com
hospital mortality across surgeon volume but used
only marginal volume cut-offs (low volume ≤1 cases/
year and high volume >1.5 cases/year).
Few studies have investigated the effects of institu-
tional structural variables and processes of care in the
treatment pathway for cystectomy. Some evidence
from the United States suggests that adjusting for pro-
cesses of care before, during, and after radical cystect-
omy accounts for 23% of the volume-mortality effect.13
Institutional structural variables can attenuate the
volume-mortality relation by up to 59%.12
Implications for clinicians and policymakers
Interpretation of the institutional volume-mortality
relation reported in this study was only possible after
adjustment for institutional structural and process of
care variables. Adjusting for these confounders, in
addition to case mix, must be done before considering
the use of volume-outcome data to support centralisa-
tion of care to a few high volume centres specialising in
radical cystectomy for bladder cancer. We made no
effort to determine causal relations between individual
structural and process of care measures and mortality
after radical cystectomy, and this will need to be the
subject of further research. This will also need to be
combined with research exploring the volume-out-
come relation for outcomes other thanmortality.Mor-
tality is only one of several outcomes that need to be
examined when trying to improve the quality of care
for patients. Longer term outcomes including func-
tional morbidity and disease recurrence may ulti-
mately influence towards centralising care and so
help inform the future design and reconfiguration of
services.
Longitudinal data analysis is essential for assessing
causality and causal direction, as it indicates whether
outcomes improve if annual volume of activity
increases over time. As previously reported,23 studies
that have shown volume-outcome relations on cross
sectional analysis have subsequently found no relation
between changes in volume and outcome over time.
The absence of reliable longitudinal data in volume-
outcome research has been highlighted as a concern
when trying to predict, with any certainty, the success
of centralising services to improve outcomes.20
Adjustment for structural and process of care vari-
ables seemed to have the most impact at the level of
medium volume institutions. The difficulties and dan-
gers of trying to define an absolute minimum caseload
are evident. More work is needed to define medium
volume institutions and also the surgeon’s volume
that makes it protective for institutional outcomes.
Centralising care to specified institutions without
accounting for the inherent structural and process fac-
tors that result in optimum care is meaningless.
Equally, the outcomes a surgeon can achieve depend
on the support network provided at the institutional
level. The relative contribution of all these factors
needs to be considered when reconfiguring service
delivery to improve the quality of care for patients.20
Unanswered questions and future research
The volume-mortality relation defined in this study is
only one component of a much broader future quality
assessment matrix that must combine other integral fac-
tors, such as adherence to process of care measures
encompassing the entire patient treatment pathway;
other outcomes of surgery, including longer term clini-
cal outcomes (cancer recurrence rates and cancer speci-
fic survival); patient reported measures, including
quality of life assessment; and assessment of patient satis-
faction and experience. We have not included volumes
of other related operations that may influence mortality
risk. The impact of overall uro-oncological operative
volumes has been highlighted and, for cystectomy,
adjustment for institutional volumes of nephrectomies
and prostatectomies attenuated the institutional cystect-
omy volume-mortality relation by 60%.24 This is parti-
cularly important for health care in England, and
guidance for improving outcomes for urological cancer
services, as the minimum caseload guidance for radical
pelvic surgery of 50 cases per year considers cystectomy
and prostatectomy in combination.
Further research needs to explore the relative con-
tributions of each of the factors, the institution, the sur-
geon, and individual characteristics of structural and
process of care, and explore the relation between case-
load volume and operative outcomes other than mor-
tality. This, in combination with further efforts to
improve the methods used for volume-outcome
research, will be important for informing future
changes to healthcare services, such as centralising
care for relatively uncommon operations such as radi-
cal cystectomy, and improving the quality of care
delivered.
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Variability in the magnitude of volume-outcome relations questioned the methodological
quality of existing studies
Over 90% of studies on volume-outcomes specific to uro-oncology have originated outside
the United Kingdom
WHAT THIS STUDY ADDS
A volume-mortality relation after radical cystectomy exists at the institutional level, and to a
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